Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
3.360
-0.415 (-10.99%)
At close: Dec 5, 2025, 4:00 PM EST
3.340
-0.020 (-0.60%)
After-hours: Dec 5, 2025, 7:40 PM EST
Artiva Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 82 | 245 | - | - | - | - | |
| Enterprise Value | -29 | 113 | - | - | - | - | |
| Last Close Price | 3.36 | 10.08 | - | - | - | - | |
| PS Ratio | - | 975.44 | - | - | - | - | |
| PB Ratio | 0.64 | 1.31 | - | - | - | - | |
| P/TBV Ratio | 0.64 | 1.31 | - | - | - | - | |
| EV/Sales Ratio | - | 450.89 | - | - | - | - | |
| Debt / Equity Ratio | 0.09 | 0.08 | 0.31 | 0.26 | 0.01 | 0.13 | |
| Asset Turnover | - | 0.00 | 0.28 | 0.03 | 0.02 | - | |
| Quick Ratio | 11.14 | 15.22 | 6.45 | 4.02 | 8.36 | 4.41 | |
| Current Ratio | 11.65 | 15.40 | 6.53 | 4.09 | 8.41 | 4.53 | |
| Return on Equity (ROE) | -47.96% | -54.24% | -44.15% | -57.84% | -99.72% | -286.85% | |
| Return on Assets (ROA) | -28.76% | -26.72% | -16.10% | -24.68% | -33.43% | -67.03% | |
| Return on Capital (ROIC) | -30.17% | -30.89% | -23.03% | -33.32% | -45.02% | -101.60% | |
| Return on Capital Employed (ROCE) | -62.50% | -34.10% | -33.00% | -55.70% | -35.40% | -77.80% | |
| Earnings Yield | -96.02% | -26.70% | - | - | - | - | |
| FCF Yield | -95.68% | -22.74% | - | - | - | - | |
| Buyback Yield / Dilution | -354.77% | -1302.54% | -4.70% | -11.80% | -8.60% | -3.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.